These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 10580423)

  • 1. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
    Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
    Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
    Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced desensitization of insulinotropic actions of sulfonylureas.
    Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
    Biochem Biophys Res Commun; 2000 Apr; 271(1):234-9. PubMed ID: 10777708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
    Chan SL; Dunne MJ; Stillings MR; Morgan NG
    Eur J Pharmacol; 1991 Oct; 204(1):41-8. PubMed ID: 1687123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
    Chan SL; Mourtada M; Morgan NG
    Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds.
    Bleck C; Wienbergen A; Rustenbeck I
    Diabetes; 2004 Dec; 53 Suppl 3():S135-9. PubMed ID: 15561901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific desensitization of sulfonylurea- but not imidazoline-induced insulin release after prolonged tolbutamide exposure.
    McClenaghan NH; Ball AJ; Flatt PR
    Biochem Pharmacol; 2001 Mar; 61(5):527-36. PubMed ID: 11239495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
    Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
    Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
    Shepherd RM; Hashmi MN; Kane C; Squires PE; Dunne MJ
    Br J Pharmacol; 1996 Nov; 119(5):911-6. PubMed ID: 8922740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y; Anello M; Henquin JC
    Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIP2 and ATP cooperatively prevent cytosolic Ca2+-induced modification of ATP-sensitive K+ channels in rat pancreatic beta-cells.
    Koriyama N; Kakei M; Nakazaki M; Yaekura K; Ichinari K; Gong Q; Morimitsu S; Yada T; Tei C
    Diabetes; 2000 Nov; 49(11):1830-9. PubMed ID: 11078449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
    Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
    Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels.
    Szollosi A; Nenquin M; Henquin JC
    Br J Pharmacol; 2010 Feb; 159(3):669-77. PubMed ID: 20128805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pinacidil, RP 49356 and nicorandil on ATP-sensitive potassium channels in insulin-secreting cells.
    Dunne MJ
    Br J Pharmacol; 1990 Mar; 99(3):487-92. PubMed ID: 2158844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of imidazoline compounds on cytoplasmic Ca2+ concentration and ATP-sensitive K+ channels in pancreatic B-cells.
    Rustenbeck I; Kowalewski R; Herrmann C; Dickel C; Ratzka P; Hasselblatt A
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():42-5. PubMed ID: 8839253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIN14B: a pancreatic delta-cell line that maintains functional ATP-dependent K+ channels and capability to secrete insulin under conditions where it no longer secretes somatostatin.
    Bränström R; Höög A; Wahl MA; Berggren PO; Larsson O
    FEBS Lett; 1997 Jul; 411(2-3):301-7. PubMed ID: 9271225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
    Bleck C; Wienbergen A; Rustenbeck I
    Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies.
    Rustenbeck I; Dickel C; Grimmsmanns T
    Biochem Pharmacol; 2001 Dec; 62(12):1695-703. PubMed ID: 11755123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets.
    Straub SG; James RF; Dunne MJ; Sharp GW
    Diabetes; 1998 May; 47(5):758-63. PubMed ID: 9588447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazolines and the pancreatic B-cell. Actions and binding sites.
    Rustenbeck I; Köpp M; Ratzka P; Leupolt L; Hasselblatt A
    Ann N Y Acad Sci; 1999 Jun; 881():229-40. PubMed ID: 10415921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.